Abstract

BackgroundCurrent laboratory diagnosis of Buruli ulcer (BU) is based on microscopic detection of acid fast bacilli, quantitative real-time PCR (qPCR), histopathology or cultivation. Insertion sequence (IS) 2404 qPCR, the most sensitive method, is usually only available at reference laboratories. The only currently available point-of-care test, microscopic detection of acid fast bacilli (AFB), has limited sensitivity and specificity.Methodology/ Principal FindingsHere we analyzed AFB positive tissue samples (n = 83) for the presence, distribution and amount of AFB. AFB were nearly exclusively present in the subcutis with large extracellular clusters being most frequently (67%) found in plaque lesions. In ulcerative lesions small clusters and dispersed AFB were more common. Beside this, 151 swab samples from 37 BU patients were analyzed by IS2404 qPCR and ZN staining in parallel. The amount of M. ulcerans DNA in extracts from swabs correlated well with the probability of finding AFB in direct smear microscopy, with 56.1% of the samples being positive in both methods and 43.9% being positive only in qPCR. By analyzing three swabs per patient instead of one, the probability to have at least one positive swab increased from 80.2% to 97.1% for qPCR and from 45% to 66.1% for AFB smear examination.Conclusion / SignificanceOur data show that M. ulcerans bacteria are primarily located in the subcutis of BU lesions, making the retrieval of the deep subcutis mandatory for examination of tissue samples for AFB. When laboratory diagnosis is based on the recommended less invasive collection of swab samples, analysis of three swabs from different areas of ulcerative lesions instead of one increases the sensitivity of both qPCR and of smear microscopy substantially.

Highlights

  • Buruli ulcer (BU) is a devastating disease of the skin and subcutis, resulting from infection with Mycobacterium ulcerans [1,2,3]

  • Four laboratory methods are available to diagnose Buruli ulcer, a neglected tropical skin disease caused by Mycobacterium ulcerans affecting mainly children in remote rural areas of West Africa

  • Our results on the distribution of M. ulcerans in Buruli ulcer lesions emphasize that the sensitivity of Buruli ulcer laboratory diagnosis is dependent on optimal sampling procedures

Read more

Summary

Introduction

Buruli ulcer (BU) is a devastating disease of the skin and subcutis, resulting from infection with Mycobacterium ulcerans [1,2,3]. The differential diagnosis of BU includes diseases like cutaneous tuberculosis, cutaneous leishmaniasis and squamous cell carcinoma [3] Because of this and because the current standard antibiotic treatment is associated with relevant side effects it is important to reconfirm the initial clinical diagnosis by a laboratory test. Compared to qPCR, both microscopy and culture have limited sensitivity and may give false negative results [5] This is in part due to the uneven distribution of the bacteria in BU lesions. Current laboratory diagnosis of Buruli ulcer (BU) is based on microscopic detection of acid fast bacilli, quantitative real-time PCR (qPCR), histopathology or cultivation. The only currently available point-of-care test, microscopic detection of acid fast bacilli (AFB), has limited sensitivity and specificity

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call